Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
This study is testing the investigational drug, cetuximab, in combination with different
chemotherapy drugs for lung cancer. The aim of the study is to determine which of the drug
combinations looks most promising and should be tested further. The study will also look at
what side effects may occur.